June 20, 2013
Calling for EU Investment in Humane and Human-Relevant Science
“Animal models” of human disease, created artificially in the laboratory, are increasingly being exposed as poor predictors of actual human diseases in the real world.
Just last month, Harvard University professor H Shaw Warren and colleagues reported that out of 150 treatments for severe inflammation found to be effective in treating mice in the laboratory, not a single one has proved effective in people.
The month prior, Swiss scientists reported that nine out of every 10 autism studies using animal models are flawed. And these examples are just the tip of the iceberg.
Humane Society International is working around the globe with scientists and research funding bodies to redirect investments away from failing animal models in favour of modern, human biology-based approaches. It is these truly human-relevant techniques that are best equipped to unlock the answers to human illnesses that currently elude us.
Help end animal testing of cosmetics: Pledge to Be Cruelty-Free.
In Europe, we’ve led a two-year effort to ensure that the next multi-annual EU research funding program, Horizon 2020, includes substantial, dedicated funding to enhance the science and technology infrastructure needed to fully replace animal use in safety testing and to deliver new, non-animal tools for medical research. We’ve organized high-profile briefings and secured critical directional language during the political negotiations. And some of the world’s largest consumer product, chemical and pharmaceutical companies—Dow, DuPont, ExxonMobil, Johnson & Johnson, L’Oréal, Procter & Gamble and Unilever—have aligned themselves with HSI and our vision of “21st century” safety science.
Together we’re making unprecedented progress toward a future of science without suffering, and progress without pain. Will you help us?